ZURICH/BERLIN, Oct 18 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Monday:
ROCHE ROG.S
The head of Roche's controlling group of shareholders is
"very confident" stability can be maintained at the
pharmaceuticals company after the next generation of heirs
joined the family pool of investors, he told NZZ am Sonntag.
urn:newsml:reuters.com:*:nL1N2RD038
COMPANY STATEMENTS
* Roche's ROG.S subsidiary Genentech said U.S. Food and
Drug Administration (FDA) had approved its Tecentriq drug as
adjuvant treatment for certain people with early non-small cell
lung cancer. ROG.S
* Santhera Pharmaceuticals Holding AG SANN.S said revenue
fell to 4.5 million Sfr in the first half of the year. SANN.S
* Allreal ALLN.S said it had closed an acquisition of
companies previously belonging to Immosynergies Holding.
ALLN.S
* Bachem Holding BANB.S said its extraordinary general
meeting approved proposals to create an authorized share capital
and to amend bylaws. BANB.S
ANALYSTS VIEWS
UBS GROUP AG UBSG.S : CREDIT SUISSE RAISES TARGET PRICE TO
CHF 18.5 FROM CHF 18
VAT GROUP AG VACN.S : JP MORGAN RAISES TARGET PRICE TO CHF
392 FROM CHF 375
ECONOMY
SNB data on Swiss sight deposits due at 0800 GMT.
(Reporting by Zurich newsroom and Berlin Speed Desk)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))